The FDA has approved Kresladi, the first gene therapy for severe Leukocyte Adhesion Deficiency Type I. Designed for pediatric patients without a suitable donor, the therapy modifies a patient’s own ...

Aussies were left stunned by the 'incredibly eerie' sight that they were met with on Friday (27 March) thanks to Cyclone ...

Marne-cel now offers an option to children with the rare immune disorder who lack a sibling donor for stem cell ...

Kids with severe LAD-I, caused by ITGB2 mutations, are at risk of life-threatenin ...

Rocket Pharmaceuticals (NASDAQ:RCKT) said the U.S. Food and Drug Administration has granted accelerated approval to KRESLADI ...

UFC commentator Joe Rogan shared some details about the 'very weird' medical procedure he recently underwent, which is known ...

"I'm not quite ready to give all that up just yet." Woakes (left) celebrating with Dom Sibley winning the 2021 Championship ...

Alicia and Jon Langenhop's three children were each diagnosed with a rare disorder. A clinical trial was "a no-brainer." ...

Daniel has been playing games for entirely too many years, with his Steam library currently numbering nearly 750 games and ...

Upon approval, Rocket has been awarded a priority review voucher, which currently fetch around $200m on the secondary market.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced ...

Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 ...